Introduction to Iressa (Gefitinib) 250mg
Iressa (Gefitinib) 250mg is a prescription medicine used to treat certain types of cancer, particularly non-small cell lung cancer (NSCLC). It works by targeting specific proteins that promote cancer cell growth.
Gefikin (Gefitinib) 250mg is classified under Prescription Medicines, Oncology Medicines, Targeted Cancer Drugs, and Oral Cancer Therapies. It contains Gefitinib, which inhibits epidermal growth factor receptor (EGFR) activity, helping slow or stop tumor progression.
In some markets, generic versions of Gefikin 250mg are available containing the same active ingredient Gefitinib, offering similar therapeutic benefits when prescribed by a qualified healthcare professional.
What Is Gefikin (Gefitinib)?Â
Gefikin is the brand name for Gefitinib, an oral targeted therapy used in cancer treatment.
Gefitinib belongs to a class of medicines known as Tyrosine Kinase Inhibitors (TKIs). These medicines block signals that allow cancer cells to grow and divide.
Generic versions such as Gefikin 250mg contain the same active compound and may be used depending on physician recommendation and availability.
Drug Class and Mechanism of ActionÂ
Gefitinib is classified as an EGFR tyrosine kinase inhibitor with strong antineoplastic properties.
How Gefitinib WorksÂ
It works in several ways:
- Inhibits EGFR signaling pathways
- Blocks cancer cell growth and division
- Promotes cancer cell death
Through these mechanisms, Gefitinib helps control tumor progression in certain cancers.
How Gefikin Works in the BodyÂ
Cancer cells often grow due to abnormal signaling pathways. Gefikin blocks these signals to control tumor growth.
Key Actions of GefitinibÂ
- Targets EGFR-mutated cancer cells
- Inhibits tumor growth signals
- Slows disease progression
Medical Uses of Gefikin (Gefitinib) 250mgÂ
Gefikin 250mg is widely prescribed in oncology treatment.
Gefikin for Non-Small Cell Lung Cancer (NSCLC)Â
Used in patients with EGFR mutation-positive NSCLC.
Potential BenefitsÂ
- Improved progression-free survival
- Targeted therapy with fewer systemic effects
- Better disease control
Who Can Take Gefikin 250mg?Â
Gefitinib therapy should be supervised by an oncologist.
Eligibility CriteriaÂ
Patients may be prescribed Gefikin if they:
- Have confirmed NSCLC with EGFR mutation
- Are suitable for targeted therapy
- Can undergo regular monitoring
Who Should Avoid Gefikin (Gefitinib) 250mgÂ
Gefikin should NOT be used by:
- Pregnant or breastfeeding women
- Individuals with hypersensitivity to Gefitinib
- Patients with severe lung or liver conditions unless monitored
Gefikin (Gefitinib) 250mg Dosage and AdministrationÂ
Standard Dosage GuidelinesÂ
Typical dosage recommendations include:
- Gefikin 250mg once daily
- Can be taken with or without food
- Tablets should be swallowed whole
Dosage AdjustmentsÂ
Doctors may adjust the dose depending on:
- Patient tolerance
- Liver function
- Side effects
Side Effects of Iressa (Gefitinib) 250mg
Common Side EffectsÂ
- Skin rash
- Diarrhea
- Nausea
- Loss of appetite
Serious Side EffectsÂ
- Interstitial lung disease (rare but serious)
- Liver toxicity
- Severe skin reactions
Patients should report breathing difficulty or severe symptoms immediately.
Storage:
Store below 25°C in a cool, dry place, protected from sunlight and moisture. Keep out of reach of children.
Frequently Asked Questions (FAQs)Â
1. What type of cancer is Gefikin used for?Â
It is primarily used for non-small cell lung cancer with EGFR mutation.
2. Is Gefikin chemotherapy?Â
No, it is a targeted therapy, not traditional chemotherapy.
3. Can Gefikin be taken long-term?Â
Yes, it may be used as long as it remains effective and tolerated.
4. Can I take it with food?Â
Yes, it can be taken with or without food.
5. Does Gefikin cause hair loss?Â
Hair loss is less common compared to chemotherapy.
6. Is Gefikin 250mg the same as generic Gefitinib?Â
Yes, it contains the same active ingredient Gefitinib.
7. Do I need a prescription to buy Gefikin 250mg?Â
Yes, it is a prescription-only medicine.
Medical DisclaimerÂ
Disclaimer:
The information provided here is for educational purposes only and should not be considered medical advice. Gefikin (Gefitinib) is a prescription medicine and must be used under the supervision of a qualified healthcare professional.



